Title
WHEREAS, like the City of Pittsburgh, the nation of Cuba is home to prestigious and successful medical, public health, pharmaceutical, and life sciences research, having contributed heavily and with international regard to treatment regimens used in previous outbreaks of Ebola, Zika, Chikungunya, and other novel viruses; and
Body
WHEREAS, Cuba's response to the Covid-19 pandemic has been recognized internationally for its favorable fatality and recovery rates, including its use of the Cuba-produced drugs Biomodulina T, Heberon Interferon Akfa 2B human recombinant, Itolizumab, Jusvinza, and CIBG 258, as well as the Soberana 02 vaccine that's entering trials; and
WHEREAS, despite more than 42 countries currently in the process of acquiring or already having acquired pharmaceutical treatments for Covid-19 from Cuba, none have been made available to United States residents because of ongoing restrictions against collaboration with and imports from Cuba due to Trump Administration policies; and
WHEREAS, The City of Pittsburgh has been home to the Pittsburgh-Matanzas Sister Cities Partnership and has supported numerous resolutions encouraging friendship and mutual cooperation with the people of Cuba and several Pittsburgh-based academic, medical, and innovation institutions are now working individually and collaboratively to produce breakthrough treatments and medical approaches to best the devastating effects of the Covid-19 pandemic and its associated death rate; and
WHEREAS, recent proclamations and resolutions from cities such as Cleveland, Richmond, San Francisco, and more calling for the lifting of the U.S.-backed embargo on Cuba that has severely restricted cooperation on scientific and medical research speaks to the ongoing national awareness and work toward similar collaborative initiatives; and
WHEREAS, past City of Pittsburgh resolutions calling for the normalization of relationships between these two countries have been passed without opposition...
Click here for full text